INTERLEUKIN GENETICS INC 4
4 · INTERLEUKIN GENETICS INC · Filed Jan 26, 2017
Insider Transaction Report
Form 4
Toutain Stephan
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-01-25+365,093→ 365,093 totalExercise: $0.12Exp: 2027-01-25→ Common Stock (365,093 underlying)
Footnotes (2)
- [F1]The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on January 25, 2017, which was the grant date of the option.
- [F2]The option vests as to 25% of the shares on January 25, 2018, and 1/36th of the shares on the first day of each month beginning on February 1, 2018.